Avadel Pharmaceuticals plc
USD21.64
+0.00 (+0.00%)
CEO
Gregory J. Divis Jr.
IPO Date
1996-06-07
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
IE
Open
$21.64
Prev. Close
$21.64
Day Low
$21.64
Day High
$21.64
52W Low
$6.38
52W High
$23.57
Market Cap
$2.12B
Volume
35.02M
| -7.1 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | 650.1% | -103.5% | -6.20 | 1.81 | -3.1 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -98.8% | -31.3% | 1.85 | 9.17 | -6.1 |
| 31 Dec 2020 | FY | 74.3% | 31.5% | 4.3% | 2.3% | 0.80 | 17.44 | 50.4 |
| 31 Dec 2019 | FY | 79.5% | -56.1% | 113.8% | -21.9% | -4.27 | 2.29 | -8.5 |
| 31 Dec 2018 | FY | 83.0% | -92.3% | -3428.2% | -50.1% | 41.67 | 3.25 | -1.0 |
| 31 Dec 2017 | FY | 90.6% | 38.9% | 79.5% | 26.7% | 0.00 | 1.44 | 4.9 |
| 31 Dec 2016 | FY | 91.2% | -27.5% | -98.1% | -16.8% | 0.02 | 2.90 | -10.4 |
| 31 Dec 2015 | FY | 93.7% | 23.5% | 59.9% | 18.9% | 0.02 | 3.41 | 12.2 |
| 22.1 |
| 31 Mar 2025 | Q1 | 89.4% | -9.4% | -6.6% | -2.9% | 0.04 | 2.73 | -38.4 |
| 31 Dec 2024 | Q4 | 90.5% | -10.0% | -6.8% | -3.1% | 0.02 | 2.75 | -50.2 |
| 30 Sept 2024 | Q3 | 87.7% | -5.2% | -3.5% | -1.7% | 0.03 | 2.97 | -120.3 |
| 30 Jun 2024 | Q2 | 93.3% | -33.3% | -19.7% | -8.8% | 0.03 | 2.82 | -24.6 |
| 31 Mar 2024 | Q1 | 94.4% | -100.6% | -34.9% | -16.3% | 0.03 | 2.85 | -14.0 |
| 31 Dec 2023 | Q4 | 96.4% | -148.0% | -32.8% | -17.5% | 0.03 | 3.64 | -10.5 |
| 30 Sept 2023 | Q3 | 98.3% | -517.2% | -32.9% | -17.9% | 0.50 | 3.19 | -6.3 |
| 30 Jun 2023 | Q2 | 97.6% | -4307.0% | -45.0% | -32.1% | 0.15 | 3.32 | -4.9 |